PTW-002 / Phoenicis Therap - LARVOL DELTA

Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene (clinicaltrials.gov) - P1/2 | N=8 | Not yet recruiting | Sponsor: Phoenicis Therapeutics | Trial completion date: Jul 2023 ➔ Jul 2024 | Initiation date: Oct 2022 ➔ Apr 2023 | Trial primary completion date: Apr 2023 ➔ Apr 2024

Trial completion date • Trial initiation date • Trial primary completion date

Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene (clinicaltrials.gov) - P1/2 | N=8 | Not yet recruiting | Sponsor: Phoenicis Therapeutics

New P1/2 trial